Market Cap 3.68B
Revenue (ttm) 957.80M
Net Income (ttm) 226.45M
EPS (ttm) N/A
PE Ratio 31.38
Forward PE 42.94
Profit Margin 23.64%
Debt to Equity Ratio 0.00
Volume 1,280,000
Avg Vol 2,193,738
Day's Range N/A - N/A
Shares Out 167.36M
Stochastic %K 40%
Beta 0.65
Analysts Strong Sell
Price Target $26.95

Latest News on ACAD

These Analysts Boost Their Forecasts On Acadia Pharmaceuticals

May 19, 2025, 8:25 AM EDT - 20 days ago

These Analysts Boost Their Forecasts On Acadia Pharmaceuticals


ACADIA Pharmaceuticals: Advancing On Several Fronts

May 13, 2025, 12:01 PM EDT - 26 days ago

ACADIA Pharmaceuticals: Advancing On Several Fronts


Acadia Pharmaceuticals Ends FY2024 On Solid Footing

Mar 2, 2025, 5:19 AM EST - 3 months ago

Acadia Pharmaceuticals Ends FY2024 On Solid Footing


Acadia Pharmaceuticals: Proving The Naysayers Wrong

Nov 11, 2024, 10:50 AM EST - 7 months ago

Acadia Pharmaceuticals: Proving The Naysayers Wrong


Ryan Reynolds Announces More to Parkinson's® Campaign

Aug 14, 2024, 8:04 AM EDT - 10 months ago

Ryan Reynolds Announces More to Parkinson's® Campaign


Acadia Pharmaceuticals: Back In The Buy Zone

Jun 23, 2024, 11:32 AM EDT - 1 year ago

Acadia Pharmaceuticals: Back In The Buy Zone